Mark Leuchtenberger

Mark Leuchtenberger

Vorsitzender bei NEUROSENSE THERAPEUTICS LTD.

Vermögen: 80 640 $ am 30.04.2024

67 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Mark Wayne Leuchtenberger founded Mercator Therapeutics, Inc. in 2009, where he worked as Director from 2009 to 2012.
Mr. Leuchtenberger also founded Albor Biologics, Inc. and Alvos Therapeutics, Inc. Mr. Leuchtenberger also currently works at Spybiotech Ltd., as Chief Executive Officer from 2022, Neurosense Therapeutics Ltd., as Chairman from 2021, Wake Forest University, as Director, and NeuroHealing Pharmaceuticals, Inc., as Director from 2013.
Mr. Leuchtenberger also formerly worked at Acusphere, Inc., as Chairman, President & Chief Executive Officer from 2013 to 2015, Chiasma, Inc., as President, Chief Executive Officer & Director from 2015 to 2016, Targanta Therapeutics Corp., as President & Chief Executive Officer from 2006 to 2009, Melinta Subsidiary Corp., as President, Chief Executive Officer & Director from 2011 to 2013, Therion Biologics Corp., as President & Chief Executive Officer, Eterna Therapeutics LLC, as President & Chief Executive Officer from 2018 to 2019, Eterna Therapeutics, Inc., as Chief Executive Officer from 2017 to 2019, IRX Therapeutics, Inc., as President, Chief Executive Officer & Director from 2017 to 2019, Xenetic Biosciences, Inc., as Non-Executive Chairman from 2014 to 2015, Aleta Biotherapeutics, Inc., as Executive Chairman, EPIX Pharmaceuticals, Inc., as Director, Beth Israel Deaconess Medical Center, Inc., as Director, and Massachusetts Biotechnology Council, as Director.
Mr. Leuchtenberger received his undergraduate degree from Wake Forest University and Masters Business Admin degree from Yale School of Management.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
01.04.2024 64 000 ( 0,37% ) 80 640 $ 30.04.2024

Aktive Positionen von Mark Leuchtenberger

UnternehmenPositionBeginn
NEUROSENSE THERAPEUTICS LTD. Vorsitzender 01.10.2021
Direktor/Vorstandsmitglied 03.09.2013
Wake Forest University Direktor/Vorstandsmitglied -
Vorstandsvorsitzender 12.07.2022
Alle aktiven Positionen von Mark Leuchtenberger

Ehemalige bekannte Positionen von Mark Leuchtenberger

UnternehmenPositionEnde
ETERNA THERAPEUTICS INC. Vorstandsvorsitzender 01.12.2019
Vorstandsvorsitzender 01.12.2019
Vorstandsvorsitzender 01.12.2019
CHIASMA, INC. Vorstandsvorsitzender 01.10.2016
XENETIC BIOSCIENCES, INC. Vorsitzender 16.04.2015
Sehen Sie sich die Erfahrung von Mark Leuchtenberger im Detail an

Ausbildung von Mark Leuchtenberger

Wake Forest University Undergraduate Degree
Yale School of Management Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Mark Leuchtenberger im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

21

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen4
ACUSPHERE, INC.

Health Technology

XENETIC BIOSCIENCES, INC.

Health Technology

NEUROSENSE THERAPEUTICS LTD.

Health Technology

ETERNA THERAPEUTICS INC.

Health Technology

Private Unternehmen15

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Commercial Services

Health Technology

Albor Biologics, Inc.

Health Technology

Health Technology

Health Technology

Commercial Services

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Mark Leuchtenberger